Quick answers
Did Amos Adler found MEMOTEXT?
Yes. MEMOTEXT's own About page, checked September 22, 2026, lists Amos Adler as "Founder and President" and places the company's foundation in 2012. MedCity News, on September 18, 2017, also identified him as Memotext's founder and president in a piece on measuring return on investment in patient engagement.
Is Amos Adler still MEMOTEXT's CEO?
The CEO title could not be confirmed. On MEMOTEXT's About page, checked September 22, 2026, Adler is listed as "Founder and President" and no one carries a CEO title: Alex Ostritsky is listed as Chief Technology Officer and Thomas Corcoran as Chair. The company used the same "Founder and President of MEMOTEXT" wording in its April 29, 2015 announcement of an alliance with STI Technologies. Directory and profile sites list him as "Founder, President and CEO", but no page we opened supports the CEO part.
Has MEMOTEXT been acquired?
No acquisition was found. MEMOTEXT's home page and About page, both checked September 22, 2026, name no parent company and list the company's own offices in Toronto and Bethesda, Maryland, describing it as "Trusted since 2012". Its tie-up with STI Technologies, announced April 29, 2015, was a strategic alliance rather than a purchase.
What does MEMOTEXT do?
Its home page, checked September 22, 2026, describes MEMOTEXT as "a platform and marketplace for co-created patient engagement" that helps teams "build, validate and scale secure digital health interventions". MedCity News reported on September 18, 2017 that the company had built products for medication and care-plan adherence, care coordination, treatment initiation and population health management, with research partners including Massachusetts General Hospital, the Centre for Addiction and Mental Health and the University of British Columbia.